Plastic products supplier Coral Products (LON: CRU) says full year sales will be slightly lower at £30.5m, but profit will be much better than expected. Cash was £750,000 at the end of April 2025. This year profitability is significantly better than anticipated and there will be an initial contribution from Arrow Film Converters. The strategies of the subsidiaries have been updated. The share price recovered 29% to 10p.
Premier African Minerals (LON: PREM) says that the Zulu lithium plant restarted on 6 July and optimisation will follow. The share price increased 28.6% to 0.0155p.
Jarvis Securities (LON: JIM) has confirmed the sale of its execution-only broker business to Interactive Investor. The initial £9m will be paid shortly and the other £2m deferred for up to 18 months. The settlement business is being wound down and the company will become a shell. The share price improved 16.7% to 21p.
Thor Energy (LON: THR) reports what it describes as outstanding results of the soil geochemistry study at the HY-Range project in South Australia. This shows significantly elevated helium and hydrogen. Helium is up to 27ppm and several hydrogen values are more than 1,000ppm. Four focus areas are identified. The share price is 15.8% higher at 0.55p.
MTI Wireless Edge (LON: MWE) has won three contracts for the supply of military antennas worth $1.6m in total. These will be delivered over the next 20 months. The share price rose 6.67% to 48p.
FALLERS
Water and energy efficiency technology services provide Eneraqua Technologies (LON: ETP) says revenues will be low than expected for the year to January 2025, but pre-tax profit will be in line with forecasts. Revenues of £81m were forecast but the outcome is going to be £63m. A £7m project substantially completed last year is recognised as accrued revenues. There have been delays in the receipt of payments and further deferral of projects in the current year. This has led to the requirement for additional funding. The disposal of a non-core business should raise £1m. The share price slumped 34.5% to 19p.
Predictive genetics company GENinCode (LON: GENI) says that the FDA still believes that there are deficiencies in relation to the de Novo submission for CARDIO inCode. Management believes that these deficiencies can be addressed, but there is no guarantee that this will be sufficient for the FDA. There are ongoing clarification discussions. In 2024, revenues were one-quarter higher at £2.7m. GENinCode has started to generate revenues in the US but the major growth came from the UK and the Europe. The 2025 forecasts assume most of the growth in revenues to £4.3m will continue to come from the UK and Europe. Cash will last into next year. The share price slipped 22.2% to 1.75p. losing most of the gains after the recent results.
Pantheon Resources (LON: PANR) has raised $16.25m at 21.15p/share and it is redeeming $11.4m of convertible bonds though the issue of shares at the same price. Michael Spencer will own more than 8% of the oil and gas explorer. The cash will fund drilling. The share price fell 11.5% to 21.775p.